Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of HTD1801 in type 2 diabetes inadequately controlled on metformin
CTR20233438Phase 3Completed
- Sponsor
- Juntesun Bioscience
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of berberine ursodeoxycholate in type 2 diabetes mellitus (T2DM), sponsored by Juntesun Bioscience. Started Nov 2023; status: completed.
02
Drugs
berberine ursodeoxycholate
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20233438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233438.